Table 2.
Performance comparisons of GrwLDA, LRLSLDA and KATZLDA methods based on the newly collected lncRNAs associated with colon, gastric and kidney cancer by the updates of LncRNADisease database and their ranking of the three methods.
| disease | lncRNA | LRLSLDA | KATZLDA | GrwLDA |
|---|---|---|---|---|
| Colon cancer | HOTAIR | 2 | 2 | 1 |
| Colon cancer | CRNDE | 19 | 31 | 3 |
| Colon cancer | MALAT1 | 1 | 1 | 2 |
| Colon cancer | KCNQ1OT1 | 8 | 23 | 5 |
| Colon cancer | LSINCT5 | 21 | 11 | 15 |
| Gastric cancer | H19 | 2 | 1 | 1 |
| Gastric cancer | HOTAIR | 1 | 5 | 2 |
| Gastric cancer | MEG3 | 3 | 2 | 3 |
| Gastric cancer | PVT1 | 4 | 3 | 4 |
| Gastric cancer | CDKN2B-AS1 | 7 | 6 | 7 |
| Gastric cancer | LSINCT5 | 14 | 15 | 23 |
| Gastric cancer | UCA1 | 70 | 19 | 16 |
| Gastric cancer | SPRY4-IT1 | 72 | 44 | 45 |
| Kidney cancer | H19 | 6 | 1 | 1 |
| Kidney cancer | PVT1 | 12 | 3 | 3 |
| Kidney cancer | MEG3 | 15 | 2 | 7 |
| Kidney cancer | MALAT1 | 26 | 4 | 10 |
| Kidney cancer | GAS5 | 45 | 15 | 29 |
| Kidney cancer | KCNQ1OT1 | 66 | 36 | 37 |
| Average ranking of the three diseases | 20.74 | 11.79 | 11.26 | |